Alejandro Olive
Overview
Explore the profile of Alejandro Olive including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
804
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lovgach O, Plaza Z, Castro M, Rosas J, Martinez-Taboada V, Olive A, et al.
J Rheumatol
. 2025 Jan;
52(3):257-262.
PMID: 39814434
Objective: We aimed to quantify the mortality risk in a large, well-characterized cohort of patients with Sjögren disease (SjD) and to identify independent predictors of mortality in this population. Methods:...
2.
Narvaez J, Palacios-Olid J, Garcia de Yebenes M, Holgado S, Olive A, Casafont-Sole I, et al.
J Clin Med
. 2025 Jan;
14(1.
PMID: 39797367
To investigate the prevalence and clinical spectrum of atypical or non-classical complications in adult-onset Still's disease (AOSD) beyond macrophage activation syndrome (MAS) and to identify factors linked to their occurrence....
3.
Anton J, Mosquera J, Calzada J, Iglesias E, Zacarias A, Olive A, et al.
Rheumatol Int
. 2024 Sep;
44(12):2911-2920.
PMID: 39311913
To describe the characteristics of systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still's disease (AOSD), compare their presentation and evolution, and analyse possible complication predictors. Multicenter study. Data were retrieved...
4.
Altabas-Gonzalez I, Rua-Figueroa I, Mourino C, Roberts K, Jimenez N, Martinez-Barrio J, et al.
Lupus Sci Med
. 2024 Aug;
11(2.
PMID: 39097409
Objective: To assess organ damage, with emphasis on the cardiovascular system, over the different stages of the disease in a large SLE cohort. Methods: Multicentre, longitudinal study of a cohort...
5.
Frade-Sosa B, Salman-Monte T, Narvaez J, Peralta I, Sandoval S, Magallares B, et al.
Lupus
. 2024 Mar;
33(5):481-489.
PMID: 38446533
Background: In 2017, belimumab (BEL) was approved in subcutaneous (SQ) administration. The effectiveness after switching from intravenous (IV) to SQ and patient satisfaction in daily clinical practice has not been...
6.
Magro-Checa C, Ramiro S, Rua-Figueroa I, Jimenez N, Del Campo-Perez V, Martinez-Barrio J, et al.
Semin Arthritis Rheum
. 2022 Nov;
58:152121.
PMID: 36375359
Objectives: To analyze the prevalence, incidence, survival and contribution on mortality of major central nervous system (CNS) involvement in systemic lupus erythematosus (SLE). Methods: Patients fulfilling the SLE 1997 ACR...
7.
Rodriguez-Muguruza S, Combe B, Guillemin F, Fautrel B, Olive A, Marsal S, et al.
Clin Exp Rheumatol
. 2021 Oct;
40(7):1361-1367.
PMID: 34596027
Objectives: In a cohort of early rheumatoid arthritis (RA) patients, we aimed to determine and characterise fatigue trajectories over 10 years of follow-up and identify predictors of trajectory membership. Methods:...
8.
Villuendas R, Martinez-Morillo M, Junca G, Teniente-Serra A, Diez C, Heredia S, et al.
Lupus
. 2021 Jul;
30(10):1596-1602.
PMID: 34192953
Objectives: Recent data suggest that some adult patients with autoimmune rheumatic diseases may develop cardiac conduction and repolarization abnormalities mediated by anti-Ro/SSA antibodies. We aim to investigate the utility of...
9.
Aparicio-Rovira M, Riveros A, Luna D, Canete F, Olive A
Gastroenterol Hepatol
. 2021 May;
45 Suppl 1:131-132.
PMID: 34023482
No abstract available.
10.
Prior-Espanol A, Holgado-Perez S, Olive A, Gifre L
Clin Rheumatol
. 2021 Mar;
40(9):3861-3862.
PMID: 33763797
No abstract available.